Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.
about
Prostate cancers in men with low PSA levels--must we find them?Semiparametric estimation in the proportional hazard model accounting for a misclassified cause of failureA composite metric for assessing data on mortality and causes of death: the vital statistics performance index.Declining death rates reflect progress against cancer.Racial differences in treatment and outcomes among patients with early stage bladder cancerSurvival and reduction in mortality from breast cancer. Impact of mammographic screening is not clear.Impact of screening on prostate cancer rates and trends.Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and ConnecticutClustering of trend data using joinpoint regression models.Novel diagnostic biomarkers for prostate cancer.Developing a follow-up strategy for patients with PSA ranging from 4 to 10 ng/ml via a new model to reduce unnecessary prostate biopsiesEnd-of-life expenditures by Ohio Medicaid beneficiaries dying of cancerThe value of current diagnostic tests in prostate cancer screening.Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries.Quantifying the role of PSA screening in the US prostate cancer mortality decline.Prostate cancer incidence and mortality rates and trends in the United States and CanadaAge-period-cohort models in cancer surveillance research: ready for prime time?The war on cancer: a report from the front linesProstate cancer incidence and mortality in barbados, west indies.Modeling causes of death: an integrated approach using CODEmExpectant management: an option for localized prostate cancer.Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality TrendsTemporal trends in cause of death among Swedish and US men with prostate cancer.Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96Isotonic estimation of survival under a misattribution of cause of death.An examination of the dynamic changes in prostate-specific antigen occurring in a population-based cohort of men over time.Disparities in long-term radiographic follow-up after cystectomy for bladder cancer: Analysis of the SEER-Medicare databaseModel-based patterns in prostate cancer mortality worldwideAssessment of causes of death in a prostate cancer screening trial.Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up.Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committeeWhat we have learned from randomized trials of prostate cancer screening.Provider treatment intensity and outcomes for patients with early-stage bladder cancer.Methods and rationale used in a matched cohort study of the incidence of new primary cancers following prostate cancerProstate-cancer mortality in the USA and UK in 1975-2004: an ecological study.Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.Screening for prostate cancer: a controversy or fact.The epigenetic promise for prostate cancer diagnosis.
P2860
Q24628188-DB9E5C41-8800-4A75-A6D8-582E108B4116Q30692120-9E7BABEE-B0D3-472B-88C8-7CCDFD20A4EEQ30834314-AB6E59B1-399D-41AF-8745-CB4309C149CDQ33541029-D1D0FF1F-9EB7-4787-8EA8-42B1D834555BQ33596176-9C2D5CE4-BBDE-40AC-B447-2EACC664DE91Q33803281-9425265D-3360-4989-A3E7-947AB1600EDFQ34080713-EBBEE3FE-D3DF-4CB8-A958-A4C5CCDE87E8Q34133048-463C9A27-F578-4B20-8102-AC5191CF71B3Q34156549-06EA0EC3-988A-43FB-81BC-7AF81FE46738Q34231678-A16D764C-6F39-471D-A736-EDED3427D1F0Q34276126-64246207-14DB-45A3-BC60-F776BF26A184Q34328655-0638FEAB-614C-40B8-92EB-22EC7A114E91Q34394012-DEC80FE5-C9E9-4661-933D-DF85145BD433Q34703693-D3486625-C561-40EB-AA8A-DADBA9484425Q34703699-39C78D68-697A-49DF-B36B-71655FC26B18Q34720042-E6382AC6-50EC-465B-BEB2-CFD994B13870Q34756568-20B562D6-92B6-4F55-BE93-0AF3C10253A4Q35095188-9703B2B0-49FF-41C7-8CB4-6D21E0EDF63DQ35103643-B9A0613E-F7DE-45D2-BFEC-4952027C11ABQ35433274-58E99B47-1D38-4089-AC07-4F13E12CBDE6Q35860880-83FF967E-20B3-4BEC-BC37-AD07136AC431Q36244110-5EAC3737-AB4F-4127-80E9-84AB90864EFBQ36463900-33DF7830-4E00-4B90-9E85-0839B611B9CEQ36486777-0664E7A6-192F-47FC-B309-9D1B7726503CQ36624215-5D249645-C5E6-4C07-8D31-DC17103F41CCQ36658318-C581CC5D-74AD-4E58-BCEE-0E1B940F8B44Q36799879-B44C556D-05F4-4C38-BABF-FDBACB15415EQ36820842-67AA7BAD-5794-4EDF-B3F8-F5DFAFEF1933Q36924745-6E9198A7-003A-4C5C-A839-A74542251D92Q36970410-FE79EFC0-CAB6-45F4-9DD2-109ECC0D692AQ36979441-32A25F39-720C-4AAB-BC7B-2362C2483BEBQ37061367-8D5CAA6C-C8B1-42A3-8A52-318572AE20F2Q37084639-E0889468-C82A-45D4-84FE-91160AC82AFBQ37158594-CF124EAA-9B69-4EB1-90BA-AA1CC91EFF1CQ37278573-6C464994-C6EA-4064-B57F-365F5245A28AQ37384669-598C4B17-CED1-4DE2-9236-BAD56A55408EQ37396566-B1DFCA1F-89B3-43C1-8FA8-C1E070CC3B50Q37554717-073ECA31-1330-4A50-9580-4F0A2F4D69C9Q37803538-BEAD4B92-471E-4625-A3D7-CDF5257150BBQ37967574-8BE5A00F-2D38-49E6-8E6F-F777A2B1B17F
P2860
Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Cancer surveillance series: in ...... in prostate cancer mortality.
@en
Cancer surveillance series: in ...... in prostate cancer mortality.
@nl
type
label
Cancer surveillance series: in ...... in prostate cancer mortality.
@en
Cancer surveillance series: in ...... in prostate cancer mortality.
@nl
prefLabel
Cancer surveillance series: in ...... in prostate cancer mortality.
@en
Cancer surveillance series: in ...... in prostate cancer mortality.
@nl
P2093
P2860
P356
P1476
Cancer surveillance series: in ...... in prostate cancer mortality.
@en
P2093
P2860
P304
P356
10.1093/JNCI/91.12.1025
P407
P577
1999-06-01T00:00:00Z